🇺🇸 FDA
Patent

US 12054517

Myeloid differentiation factor 2 (MD2) signaling and modulation

granted A61KA61K38/00A61P

Quick answer

US patent 12054517 (Myeloid differentiation factor 2 (MD2) signaling and modulation) held by The Regents of the University of California expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P29/00